Alterations in drug metabolizing activities in acute hepatosteatosis induced by intake of a high-carbohydrate/fat-free diet after food deprivation
DOI:
https://doi.org/10.31989/ffhd.v6i1.238Abstract
ABSTRACT
Background: Lipid accumulation in hepatocytes constitutes a major component in the pathogenesis of chronic liver injury. However, the impact of lipid deposition in liver on drug metabolizing capacity remains unclear.
Purpose of the study: The present study was undertaken to evaluate the changes in hepatic cytochrome P-450 (CYP) enzymes in acute hepatosteatosis.
Methods: Rats were fasted for 48 h, and then provided with a high-carbohydrate/fat-free diet (FH) or a normal diet (FN) for 48 h.
Results: Hepatic lipid accumulation was significant in the FH group. In the FN group there was a small increase in microsomal p-nitrophenol hydroxylase, p-nitroanisole O-demethylase, and erythromycin N-demethylase activities, but aminopyrine N-demethylase activity was decreased markedly. However, the microsomal enzyme activities were all inhibited by FH intake. Immunoblotting analysis showed that CYP2E1, CYP1A, CYP3A, and CYP2B1/2 proteins were decreased in the FH group. Expression of corresponding CYP mRNAs was also down-regulated. A dose of CCl4, a CYP2E1 substrate,was administered to the rats fed the different diets. The liver injury was significantly lower in the FH group as determined by elevation of serum enzyme activities and histopathological examination.
Conclusions: The results show that acute hepatosteatosis may result in a significant alteration in hepatic CYP-mediated metabolizing capacity, which can precipitate erratic responses of liver to various endogenous and exogenous substances.
Key words: hepatosteatosis, cytochrome P450, non-alcoholic fatty liver disease, drug metabolizing capacity
Downloads
Published
Issue
Section
License
Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request.
Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.